Bloomsbury Publishing Plc (LON:BMY – Get Free Report) insider Leslie-Ann Reed purchased 12,139 shares of Bloomsbury Publishing stock in a transaction dated Monday, November 25th. The shares were purchased at an average price of GBX 659 ($8.35) per share, with a total value of £79,996.01 ($101,414.82).
Bloomsbury Publishing Stock Performance
LON BMY opened at GBX 660 ($8.37) on Thursday. Bloomsbury Publishing Plc has a 52-week low of GBX 410 ($5.20) and a 52-week high of GBX 766 ($9.71). The company has a debt-to-equity ratio of 4.40, a quick ratio of 1.04 and a current ratio of 1.67. The company has a market capitalization of £537.50 million, a P/E ratio of 1,712.82 and a beta of 0.66. The company has a fifty day moving average of GBX 679.68 and a 200-day moving average of GBX 664.33.
Bloomsbury Publishing Cuts Dividend
The business also recently disclosed a dividend, which will be paid on Friday, November 29th. Stockholders of record on Thursday, October 31st will be issued a dividend of GBX 3.89 ($0.05) per share. This represents a dividend yield of 0.57%. The ex-dividend date of this dividend is Thursday, October 31st. Bloomsbury Publishing’s dividend payout ratio is currently 3,846.15%.
Wall Street Analysts Forecast Growth
Read Our Latest Stock Analysis on BMY
About Bloomsbury Publishing
Bloomsbury Publishing Plc publishes academic, educational, and general fiction and non-fiction books for children, teachers, students, researchers, and professionals worldwide. The company offers books and digital resources to international research community and higher education students; online law, accounting, and tax services for the United Kingdom and professionals; and publishing services for corporations and institutions.
Read More
- Five stocks we like better than Bloomsbury Publishing
- How to Invest in the FAANG Stocks
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Canadian Penny Stocks: Can They Make You Rich?
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- How is Compound Interest Calculated?
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Bloomsbury Publishing Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bloomsbury Publishing and related companies with MarketBeat.com's FREE daily email newsletter.